- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
5 weeks to go - register NOW!
Viral Safety for Biologics 2012
27 - 28 June 2012, Pullman Hotel, Cologne, Germany
|
Optimise your viral safety screening, detection, removal and inactivation methods to minimise the risk of adventitious agents and satisfy strict regulatory requirements
Europe's Leading Viral Safety Conference
- More Regulators than any other viral safety, adventitious agent event - Compare the different opinions of the US FDA, PEI, AFSSAPS and Korena FDA on key issues such as new detection technologies, in-house generic testing and reacting to contaminations
- Prevent adventitious agents from entering your facilities by hearing the latest screening strategies being developed by BioReliance, Abbott and Genzyme - can massive parallel sequencing be used in a GMP environment?
- Exclusive, first-time data - Hear, exclusive to this conference, Baxter's latest attempts to develop an infectivity assay for PCV-1 - what challenges did they face?
- Improve your virus removal steps by discovering the latest pre-filtration and filtration strategies being developed by Pall, Sartorius, Asahi and Charles River
- Keep up-to-date with industry's increasing concern over Hepatitis E with feedback from the PEI and Benesis Corporation
- New for 2012: Dedicated TSE Evening Seminar focused on the latest detection and monitoring stratgies facing industry
- NEW for 2012: This year's Viral Safety event will be co-located with Biopharmaceutical Raw Materials: Analysis, Qualification and Supply Chain Management - access 2 events for the price of one
Latest Viral Safety Articles
Benchmark your viral safety regulatory strategy against the US FDA, PEI, AFSSAPS and Korean FDA
Benchmark your viral safety regulatory strategy against the US FDA, PEI, AFSSAPS and Korean FDA
Dr Arifa Khan
Senior Investigator
CDER, FDA, USA
|
James Bruce
Manager
Abbott Laboratories, USA
|
Glyn Stacey
Director
UK Stem Cell Bank, UK
|
Dr.Albert Stuehler
Deputy Head of Virus Safety Section
Paul-Ehrlich Institut
|
Dr Kris De Smit
Cell Culture, Operational Technical Support Lead
Genzyme, Belgium
|
Dr Ho Jung Oh,
Senior Scientific Officer and Reviewer, Biologics Division,
Korean FDA
|
..
Conference Sponsors
..
..
..
..
Exhibitors
..
..
..
..
Media Partners
..
..
..
What is Driving the 2012 Viral Safety Agenda
- New, quick-fire regulatory session with the US FDA, PEI, AFSSAPS and the Korean FDA providing you with a deeper understanding of key reglatory issues such as new detection technologies and use of in-house data
- New workshop on successfully interpreting data generated from next-generation detection technologies such as Massive Parallel Sequencing
- New sessions on how industry is responding to increased risk of Hepatitis E
- Brand new data from Novartis on how they have overcome the challenge of inactivating double-stranded viruses
- NEW for 2012: Co-located with new event, Biological Raw Materials Throughout Product Lifecycle
Join our free wine tasting session kindly sponsored by Merck Millipore - Free for all participants
Choice of 2 Interactive Workshops - Massive Parallel Sequencing Data Interpretation and TSE Evening Seminar
Interpreting Viral Safety Data Generated From New Molecular-Based Screening Technologies (Massive Parallel Sequencing)
Pre-Conference Workshop - 26 June 2012
Workshop Leader
Dr Kathryn Martin Remington, BioReliance, USA
Dr John Kolman, BioReliance, USA
Strategies for Improving the Testing and Monitoring of TSE
Evening Seminar - 27 June 2012
Workshop Leader
Dr Albrecht Gröner, CSL Behring
Dr Graham Jackson, MRC Prion Unit, UK
Dr Jillian Cooper, NIBSC, UK
Feedback from 2011's Event
"Good conference to get a feeling what’s state of the art in virus business"
"Good sharing experience from regulators and industries with take home messages"
"Good detail in current industry and regulatory views, research, actions on contamination events, future direction, specific examples etc"
Feeds | Like | Share    |
Companies booked on to attend Viral Safety 2012 so far include...
Abbott Biologicals B.V
Abbott GMBH & Co. KG
Asahi Kasei Medical (Co., Ltd.)
Asahi Kasei Pharma Corp
Bayer Business Services
Becton Dickinson
Biotest AG
CAF-DCF Redcross
Crucell Switzerland AG
EMD Millipore
GlaxoSmithKline Biologicals
Kedrion Spa
Merck Kgaa
Merck Millipore
Merck Serono
Merck Serono SA
Nordmark Arzneimittel GmbH & Co KG
Novartis Pharma AG
Novartis Vaccines & Diagnostics GmbH & CO KG
Novo Nordisk AS
Roche Diagnostics GmbH.
Sanofi Aventis Deutschland GmbH
Sanofi Aventis R & D
Sanofi Recherche & Developpement
Virusure GmbH
Conference Sponsors - 90% of Exhibition Space Already Taken. Please contact James.miguel@informa.com for more info
90% of Exhibition Space Already Taken. Please contact James.miguel@informa.com for more info
..
Who wants to be a Virology Expert?
..
..
..
